| |
| |
|
| Insider
Information: |
Scangos George A |
| Relationship: |
Director |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
937,662 |
|
|
Indirect Shares
|
3,762,360 |
|
|
| Direct
Value |
$29,588,676 |
|
|
|
Indirect Value
|
$4,891,842 |
|
|
| Total
Shares |
4,700,022 |
|
|
| Total
Value |
$34,480,518 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Exelixis Inc |
EXEL |
Director |
2020-05-18 |
714,717 |
2020-05-18 |
23,595 |
Premium* |
|
|
Anadys Pharmaceuticals Inc |
ANDS |
Director |
2008-08-26 |
33,188 |
2004-03-31 |
0 |
Premium* |
|
|
Biogen Idec Inc |
BIIB |
Chief Executive Office... |
2016-07-21 |
54,779 |
2016-07-21 |
10,756 |
Premium* |
|
|
Agilent Technologies Inc |
A |
Director |
2024-03-15 |
21,989 |
2024-03-15 |
14,450 |
Premium* |
|
|
Vir Biotechnology, Inc. |
VIR |
Director |
2024-02-26 |
112,989 |
2024-02-26 |
3,713,559 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
376 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 16
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| EXEL |
Exelixis Inc |
Director |
– • – |
2016-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
6,383 |
1,310,210 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2016-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,274 |
52,364 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2016-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
11,390 |
65,694 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2016-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,701 |
58,628 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2016-02-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,964 |
62,812 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2018-12-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
13,950 |
1,443,031 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2019-12-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
12,500 |
1,115,531 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
President and CEO |
• • – |
2021-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
111,000 |
4,609,559 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
President and CEO |
• • – |
2022-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
111,000 |
223,989 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
President and CEO |
• • – |
2022-12-21 |
4 |
AS |
$0.00 |
$0 |
I/I |
(99,968) |
827,151 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
President and CEO |
• • – |
2022-12-21 |
4 |
A |
$0.00 |
$0 |
I/I |
99,968 |
111,644 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
President and CEO |
• • – |
2023-01-18 |
4 |
A |
$0.00 |
$0 |
I/I |
64,930 |
179,930 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
President and CEO |
• • – |
2023-01-18 |
4 |
AS |
$0.00 |
$0 |
I/I |
(64,930) |
3,533,629 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
Director |
– • – |
2023-09-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,750,000 |
1,918,489 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
Director |
– • – |
2023-09-15 |
4 |
A |
$0.00 |
$0 |
I/I |
1,750,000 |
1,750,000 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
Director |
– • – |
2023-09-15 |
4 |
D |
$0.00 |
$0 |
I/I |
(5,377,590) |
0 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
Director |
– • – |
2023-10-17 |
4 |
A |
$0.00 |
$0 |
I/I |
3,500,000 |
1,750,000 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
Director |
– • – |
2023-10-17 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,750,000) |
0 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
Director |
– • – |
2023-10-17 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,750,000) |
168,489 |
0 |
- |
|
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2006-03-27 |
4 |
AS |
$11.15 |
$123 |
D/D |
(11) |
1,480,288 |
|
- |
|
| EXEL |
Exelixis Inc |
President, CEO & Director |
• • – |
2004-08-16 |
4 |
S |
$7.36 |
$736 |
D/D |
(100) |
1,639,541 |
|
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2019-01-03 |
4 |
AS |
$20.00 |
$1,920 |
D/D |
(96) |
1,403,031 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2016-12-07 |
4 |
S |
$17.90 |
$3,150 |
D/D |
(176) |
1,463,648 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2016-12-07 |
4 |
OE |
$8.99 |
$3,200 |
D/D |
356 |
1,463,824 |
0 |
- |
|
| ANDS |
Anadys Pharmaceuticals In... |
Director |
– • – |
2004-03-31 |
4 |
B |
$7.00 |
$7,000 |
D/D |
1,000 |
1,000 |
2.39 |
- |
|
376 Records found
|
|
Page 2 of 16 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
